Marlboro owner sells UK inhaler firm over backlash

UK: The tobacco giant that makes Marlboro cigarettes has sold a UK inhaler company for a knock-down price due to what it calls an “unwarranted” backlash.

Philip Morris International (PMI) has offloaded Vectura Group for £150m ($198m) just three years after buying it in a deal worth more than £1bn.

PMI’s decision to buy Vectura, which makes inhalers to treat lung conditions such as asthma, was criticised as being hypocritical.

However, PMI defended the move as part of its strategy to away from cigarettes and towards “smoke free” businesses like vaping.

ALSO READ: Sean ‘Diddy’ Combs arrested in New York City

PMI announced the sale to electronics firm Molex Asia Holdings on Wednesday, saying it releases Vectura “from the unreasonable burden of external constraints and criticism related to our ownership”.

The deal, which still needs regulatory approval, will see Molex pay an up-front fee of £150m and “potential deferred payments of up to £148m” if certain requirements are met.

PMI’s boss Jacek Olczak also said the company remains “committed to driving innovation in this space over the long-term”, suggesting it has not moved on entirely from the inhaler sector.

The Vectura purchase was part of PMI’s push towards a “smoke free world”. PMI has said it wants two thirds of its sales to come from non-cigarette sales by 2030.